Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP584948.RA20mSNW1zgDUr-4kreSs1YmIx3OygDuBWOaXa5KPxLZE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP584948.RA20mSNW1zgDUr-4kreSs1YmIx3OygDuBWOaXa5KPxLZE130_assertion type Assertion NP584948.RA20mSNW1zgDUr-4kreSs1YmIx3OygDuBWOaXa5KPxLZE130_head.
- NP584948.RA20mSNW1zgDUr-4kreSs1YmIx3OygDuBWOaXa5KPxLZE130_assertion description "[MDM2 G/G was associated with markedly reduced survival in squamous cell carcinoma (MS of 10.3 versus 49.4 months; adjusted hazard ratio for death, 7.9; 95% confidence interval, 2.4-26.0; P = 0.0007 for G/G versus T/T) but not in adenocarcinoma (SNP-histology interaction P = 0.004).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584948.RA20mSNW1zgDUr-4kreSs1YmIx3OygDuBWOaXa5KPxLZE130_provenance.
- NP584948.RA20mSNW1zgDUr-4kreSs1YmIx3OygDuBWOaXa5KPxLZE130_assertion evidence source_evidence_literature NP584948.RA20mSNW1zgDUr-4kreSs1YmIx3OygDuBWOaXa5KPxLZE130_provenance.
- NP584948.RA20mSNW1zgDUr-4kreSs1YmIx3OygDuBWOaXa5KPxLZE130_assertion SIO_000772 19383811 NP584948.RA20mSNW1zgDUr-4kreSs1YmIx3OygDuBWOaXa5KPxLZE130_provenance.
- NP584948.RA20mSNW1zgDUr-4kreSs1YmIx3OygDuBWOaXa5KPxLZE130_assertion wasDerivedFrom befree-20140225 NP584948.RA20mSNW1zgDUr-4kreSs1YmIx3OygDuBWOaXa5KPxLZE130_provenance.
- NP584948.RA20mSNW1zgDUr-4kreSs1YmIx3OygDuBWOaXa5KPxLZE130_assertion wasGeneratedBy ECO_0000203 NP584948.RA20mSNW1zgDUr-4kreSs1YmIx3OygDuBWOaXa5KPxLZE130_provenance.